Inhibition of blast cell attachment to 6h-TNF-α-activated endothelium by adhesion-blocking mAbs
| mAbs . | % Inhibition blast cell attachment . | n . | P . | |
|---|---|---|---|---|
| Mean ± SEM . | Range . | |||
| LAM 1-11 (anti-L-selectin/CD62L) | 4.3 ± 2.0 | 0-14 | 8 | — |
| LAM1-3 (anti-L-selectin/CD62L) | 50.7 ± 6.7 | 34-95 | 9 | < .001 |
| TS1/18 (anti-CD18) | 49.0 ± 5.2 | 25-81 | 11 | < .001 |
| HAE-2 (anti-VCAM-1/CD106) | 66.7 ± 7.7 | 28-98 | 8 | < .001 |
| H18/7 (anti-E-selectin/CD62E) | 57.0 ± 4.8 | 31-89 | 11 | < .001 |
| mAbs . | % Inhibition blast cell attachment . | n . | P . | |
|---|---|---|---|---|
| Mean ± SEM . | Range . | |||
| LAM 1-11 (anti-L-selectin/CD62L) | 4.3 ± 2.0 | 0-14 | 8 | — |
| LAM1-3 (anti-L-selectin/CD62L) | 50.7 ± 6.7 | 34-95 | 9 | < .001 |
| TS1/18 (anti-CD18) | 49.0 ± 5.2 | 25-81 | 11 | < .001 |
| HAE-2 (anti-VCAM-1/CD106) | 66.7 ± 7.7 | 28-98 | 8 | < .001 |
| H18/7 (anti-E-selectin/CD62E) | 57.0 ± 4.8 | 31-89 | 11 | < .001 |